A New Inhaled Treatment For Severe Hypoglycemia

blood sugar by stimulating the release of stored glucose from the liver.

The American Diabetes Association (ADA) Standards of Care recommend that glucagon be prescribed for all individuals at risk for severe hypoglycemia. Glucagon is usually given by injection beneath the skin, in the muscle or the vein.

What is Glucagon Nasal Powder?

Until recently, the only way to administer glucagon was an injection that had to be mixed in a several-step process. However, with the FDA approval of Baqsimi nasal powder, glucagon can now be inhaled. Baqsimi nasal powder is the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection

Baqsimi, which is a powder administered into the nose, comes in a single-use dispenser that can be given to someone suffering from a severe hypoglycemic episode. Baqsimi increases blood sugar levels in the body by stimulating the liver to release stored glucose into the bloodstream. It has the opposite effect of insulin, which lowers blood sugar levels.

The safety of Baqsimi nasal powder was evaluated in two studies comparing a single dose of Baqsimi to a single dose of glucagon injection. Baqsimi adequately increased

WP Twitter Auto Publish Powered By : XYZScripts.com